Proteus mirabilis - analysis of a concealed source of carbapenemases and development of a diagnostic algorithm for detection.
暂无分享,去创建一个
S. Gatermann | S. Göttig | A. Hamprecht | Janina Noster | Frieder Fuchs | Y. Stelzer | Janko Sattler | Vivien Dorth
[1] S. Göttig,et al. Emergence of Tn1999.7, a New Transposon in blaOXA-48-Harboring Plasmids Associated with Increased Plasmid Stability , 2022, Antimicrobial agents and chemotherapy.
[2] J. Vila,et al. Hidden dissemination of carbapenem-susceptible OXA-48-producing Proteus mirabilis. , 2022, The Journal of antimicrobial chemotherapy.
[3] T. Kramer,et al. High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[4] E. Bille,et al. High Prevalence of OXA-23 Carbapenemase-Producing Proteus mirabilis among Amoxicillin-Clavulanate-Resistant Isolates in France , 2021, Antimicrobial agents and chemotherapy.
[5] A. Hamprecht,et al. Detection of Multidrug-Resistant Enterobacterales—From ESBLs to Carbapenemases , 2021, Antibiotics.
[6] J. Hrabák,et al. Evidence of an epidemic spread of KPC-producing Enterobacterales in Czech hospitals , 2021, Scientific Reports.
[7] A. Hamprecht,et al. Systematic Comparison of Three Commercially Available Combination Disc Tests and the Zinc-Supplemented Carbapenem Inactivation Method (zCIM) for Carbapenemase Detection in Enterobacterales Isolates , 2021, Journal of clinical microbiology.
[8] S. Göttig,et al. OXA-484, an OXA-48-Type Carbapenem-Hydrolyzing Class D β-Lactamase From Escherichia coli , 2021, Frontiers in Microbiology.
[9] G. Cuzon,et al. A single Proteus mirabilis lineage from human and animal sources: a hidden reservoir of OXA-23 or OXA-58 carbapenemases in Enterobacterales , 2020, Scientific Reports.
[10] T. Naas,et al. Genetics of Acquired Antibiotic Resistance Genes in Proteus spp. , 2020, Frontiers in Microbiology.
[11] S. Göttig,et al. Comparison of nine different selective agars for the detection of carbapenemase-producing Enterobacterales (CPE) , 2020, European Journal of Clinical Microbiology & Infectious Diseases.
[12] S. Gatermann,et al. Comparison of five methods for detection of carbapenemases in Enterobacterales with proposal of a new algorithm. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[13] A. Hamprecht,et al. Rapid detection of OXA-48-like, KPC, NDM, and VIM carbapenemases in Enterobacterales by a new multiplex immunochromatographic test , 2018, European Journal of Clinical Microbiology & Infectious Diseases.
[14] Yirong Li,et al. The Simplified Carbapenem Inactivation Method (sCIM) for Simple and Accurate Detection of Carbapenemase-Producing Gram-Negative Bacilli , 2018, Front. Microbiol..
[15] S. Göttig,et al. Multiplex Immunochromatographic Detection of OXA-48, KPC, and NDM Carbapenemases: Impact of Inoculum, Antibiotics, and Agar , 2018, Journal of Clinical Microbiology.
[16] R. Thomson,,et al. Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae , 2017, Journal of Clinical Microbiology.
[17] S. Gatermann,et al. Dissemination of blaOXA-58 in Proteus mirabilis isolates from Germany , 2017, The Journal of antimicrobial chemotherapy.
[18] S. Gatermann,et al. Comparison of Phenotypic Tests and an Immunochromatographic Assay and Development of a New Algorithm for Detection of OXA-48-like Carbapenemases , 2016, Journal of Clinical Microbiology.
[19] A. Corso,et al. Simplified Protocol for Carba NP Test for Enhanced Detection of Carbapenemase Producers Directly from Bacterial Cultures , 2015, Journal of Clinical Microbiology.
[20] P. Nordmann,et al. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers. , 2014, The Journal of antimicrobial chemotherapy.
[21] D. Paterson,et al. Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals. , 2012, International journal of antimicrobial agents.
[22] Chi-Yu Chen,et al. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes. , 2012, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[23] D. Warren,et al. Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC β-Lactamase in P. mirabilis , 2008, Journal of Clinical Microbiology.
[24] A. Vatopoulos,et al. Emergence of Proteus mirabilis carrying the blaVIM‐1 metallo‐β‐lactamase gene , 2006 .
[25] N. Woodford,et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. , 2006, International journal of antimicrobial agents.
[26] J. Mylotte,et al. Epidemiology of bloodstream infection in nursing home residents: evaluation in a large cohort from multiple homes. , 2002, Clinical Infectious Diseases.